跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEXTSTELLIS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NEXTSTELLIS
Authorized
STANDARD
NEXTSTELLIS
searchlight pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
edd0870a515f8df3
Company
searchlight pharma inc
Type
Standard
Approval Details
Approval Id
edd0870a515f8df3
Drug Approval Canada Name
NEXTSTELLIS
Product Name
NEXTSTELLIS
Status
Marketed
Status Date
2021-06-15
Original Market Date
2021-06-15
Din
02513218
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G03AA18 DROSPIRENONE AND ESTETROL
Atc Name
g 03 aa 18
Aig Number
0262789001
Company Name
searchlight pharma inc
Company Address
1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1
Active Ingredients
DROSPIRENONE
3 MG
ESTETROL MONOHYDRATE
15 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
edd0870a515f8df3
Type
Standard
Back to Health Canada Approvals